Detalles de la búsqueda
1.
Nivolumab plus chemotherapy or ipilimumab versus chemotherapy in patients with advanced esophageal squamous cell carcinoma (CheckMate 648): 29-month follow-up from a randomized, open-label, phase III trial.
Cancer Med;
13(9): e7235, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38716626
2.
Correction to: A phase II/III randomized clinical trial of CisPlatin plUs Gemcitabine and Nabpaclitaxel (GAP) as pReoperative chemotherapy versus immediate resection in patIents with resecTable BiliarY tract cancers (BTC) at high risk for recurrence: PURITY study.
BMC Cancer;
24(1): 563, 2024 May 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-38711003
3.
A phase II/III randomized clinical trial of CisPlatin plUs Gemcitabine and Nabpaclitaxel (GAP) as pReoperative chemotherapy versus immediate resection in patIents with resecTable BiliarY Tract Cancers (BTC) at high risk for recurrence: PURITY study.
BMC Cancer;
24(1): 436, 2024 Apr 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-38589856
4.
International consensus on the management of metastatic gastric cancer: step by step in the foggy landscape : Bertinoro Workshop, November 2022.
Gastric Cancer;
2024 Apr 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-38634954
5.
NALIRIFOX, FOLFIRINOX, and Gemcitabine With Nab-Paclitaxel as First-Line Chemotherapy for Metastatic Pancreatic Cancer: A Systematic Review and Meta-Analysis.
JAMA Netw Open;
7(1): e2350756, 2024 Jan 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-38190183
6.
Rivoceranib, a VEGFR-2 inhibitor, monotherapy in previously treated patients with advanced or metastatic gastric or gastroesophageal junction cancer (ANGEL study): an international, randomized, placebo-controlled, phase 3 trial.
Gastric Cancer;
27(2): 375-386, 2024 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-38281295
7.
Anti-tumor activity of all-trans retinoic acid in gastric-cancer: gene-networks and molecular mechanisms.
J Exp Clin Cancer Res;
42(1): 298, 2023 Nov 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-37951921
8.
Assessing the safety and activity of cabozantinib combined with lanreotide in gastroenteropancreatic and thoracic neuroendocrine tumors: rationale and protocol of the phase II LOLA trial.
BMC Cancer;
23(1): 908, 2023 Sep 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-37752423
9.
Mytomicin-C, Metronomic Capecitabine, and Bevacizumab in Patients With Unresectable or Relapsed Pseudomyxoma Peritonei of Appendiceal Origin.
Clin Colorectal Cancer;
22(4): 450-456.e1, 2023 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-37657955
10.
Association between gene expression signatures and clinical outcomes of pembrolizumab versus paclitaxel in advanced gastric cancer: exploratory analysis from the randomized, controlled, phase III KEYNOTE-061 trial.
J Immunother Cancer;
11(6)2023 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-37399357
11.
Trastuzumab deruxtecan in patients in the USA and Europe with HER2-positive advanced gastric or gastroesophageal junction cancer with disease progression on or after a trastuzumab-containing regimen (DESTINY-Gastric02): primary and updated analyses from a single-arm, phase 2 study.
Lancet Oncol;
24(7): 744-756, 2023 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-37329891
12.
Final results of DESTINY-CRC01 investigating trastuzumab deruxtecan in patients with HER2-expressing metastatic colorectal cancer.
Nat Commun;
14(1): 3332, 2023 06 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-37286557
13.
Management and pharmacotherapy of pediatric colorectal carcinoma: a review.
Expert Opin Pharmacother;
24(14): 1527-1535, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37358925
14.
Fatty acid synthase as a new therapeutic target for HER2-positive gastric cancer.
Cell Oncol (Dordr);
46(3): 661-676, 2023 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-36753044
15.
HER2 Copy Number and Resistance Mechanisms in Patients with HER2-positive Advanced Gastric Cancer Receiving Initial Trastuzumab-based Therapy in JACOB Trial.
Clin Cancer Res;
29(3): 571-580, 2023 02 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36413222
16.
Platinum sensitivity in patients with IDH1/2 mutated vs wild-type intrahepatic cholangiocarcinoma: A propensity score-based study.
Int J Cancer;
151(8): 1310-1320, 2022 10 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-35723131
17.
Early onset metastatic colorectal cancer in patients receiving panitumumab-based upfront strategy: Overall and sex-specific outcomes in the Valentino trial.
Int J Cancer;
151(10): 1760-1769, 2022 11 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-35678328
18.
Preferred neoadjuvant therapy for gastric and gastroesophageal junction adenocarcinoma: a systematic review and network meta-analysis.
Gastric Cancer;
25(5): 982-987, 2022 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35704113
19.
MGMT inactivation as a new biomarker in patients with advanced biliary tract cancers.
Mol Oncol;
16(14): 2733-2746, 2022 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-35621918
20.
Metastatic pheochromocytomas and paragangliomas: where are we?
Tumori;
108(6): 526-540, 2022 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-35593402